[go: up one dir, main page]

JPS5420124A - Preparation of gamma-globulin intravenous injection - Google Patents

Preparation of gamma-globulin intravenous injection

Info

Publication number
JPS5420124A
JPS5420124A JP8446377A JP8446377A JPS5420124A JP S5420124 A JPS5420124 A JP S5420124A JP 8446377 A JP8446377 A JP 8446377A JP 8446377 A JP8446377 A JP 8446377A JP S5420124 A JPS5420124 A JP S5420124A
Authority
JP
Japan
Prior art keywords
preparation
intravenous injection
gamma
globulin
globulin intravenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8446377A
Other languages
Japanese (ja)
Other versions
JPS576404B2 (en
Inventor
Satoru Funakoshi
Yatsuhiro Kamimura
Tadakazu Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP8446377A priority Critical patent/JPS5420124A/en
Publication of JPS5420124A publication Critical patent/JPS5420124A/en
Publication of JPS576404B2 publication Critical patent/JPS576404B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE: To prepare ϒ-globulin preparation for intravenous injection having high storage stability and safety, and reduced anticomplementary titer without losing its original antibody titer, by adding a dissociating agent such as an amino acid to ϒ-globulin for intramuscular injection containing agglomerates.
COPYRIGHT: (C)1979,JPO&Japio
JP8446377A 1977-07-14 1977-07-14 Preparation of gamma-globulin intravenous injection Granted JPS5420124A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8446377A JPS5420124A (en) 1977-07-14 1977-07-14 Preparation of gamma-globulin intravenous injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8446377A JPS5420124A (en) 1977-07-14 1977-07-14 Preparation of gamma-globulin intravenous injection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP56082000A Division JPS591691B2 (en) 1981-05-29 1981-05-29 Intravenous γ-globulin preparation

Publications (2)

Publication Number Publication Date
JPS5420124A true JPS5420124A (en) 1979-02-15
JPS576404B2 JPS576404B2 (en) 1982-02-04

Family

ID=13831309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8446377A Granted JPS5420124A (en) 1977-07-14 1977-07-14 Preparation of gamma-globulin intravenous injection

Country Status (1)

Country Link
JP (1) JPS5420124A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5583711A (en) * 1978-12-18 1980-06-24 Cutter Lab Serum globulin for stabilized immunity
WO2011034604A2 (en) 2009-09-17 2011-03-24 Baxter Healthcare, S.A. Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
US8906368B2 (en) 2003-11-18 2014-12-09 Zlb Behring Ag Immunoglobulin preparations having increased stability
US9241897B2 (en) 2010-02-04 2016-01-26 Csl Behring Ag Immunoglobulin preparation
US9422364B2 (en) 2010-02-26 2016-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US10301376B2 (en) 2008-03-17 2019-05-28 Baxalta GmbH Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
US12144861B2 (en) 2014-12-03 2024-11-19 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030771A (en) * 1983-07-31 1985-02-16 ナショナル住宅産業株式会社 Tent
JPS62168930U (en) * 1986-04-17 1987-10-27

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5583711A (en) * 1978-12-18 1980-06-24 Cutter Lab Serum globulin for stabilized immunity
JPH0232261B2 (en) * 1978-12-18 1990-07-19 Cutter Lab
US8906368B2 (en) 2003-11-18 2014-12-09 Zlb Behring Ag Immunoglobulin preparations having increased stability
USRE49967E1 (en) 2008-03-17 2024-05-14 Takeda Pharmaceutical Company Limited Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
US10301376B2 (en) 2008-03-17 2019-05-28 Baxalta GmbH Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
WO2011034604A2 (en) 2009-09-17 2011-03-24 Baxter Healthcare, S.A. Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
US10137197B2 (en) 2010-02-04 2018-11-27 Csl Behring Ag Process for preparing an immunoglobulin preparation
US9241897B2 (en) 2010-02-04 2016-01-26 Csl Behring Ag Immunoglobulin preparation
US12194101B2 (en) 2010-02-04 2025-01-14 Csl Behring Ag Process for preparing an immunoglobulin preparation
US9422364B2 (en) 2010-02-26 2016-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US10434176B2 (en) 2010-02-26 2019-10-08 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US11419936B2 (en) 2010-02-26 2022-08-23 Csl Behring Ag Immunoglobulin preparation and storage system for an immunoglobulin preparation
US12144861B2 (en) 2014-12-03 2024-11-19 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins

Also Published As

Publication number Publication date
JPS576404B2 (en) 1982-02-04

Similar Documents

Publication Publication Date Title
JPS5266551A (en) Stabilizer for plastics
JPS5420124A (en) Preparation of gamma-globulin intravenous injection
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS5270432A (en) Method of two-stage burning for suppressing generation of nitrogen oxi des
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS5249254A (en) Novel iorganic filler
JPS5352622A (en) Composition for preparation of bordeaux mixture
JPS51130457A (en) Preparation of flame retardant polyamide composition
JPS51143913A (en) Method of transpoting compressed gas containing vapor of hydrocarbon s ystem compound
JPS5216540A (en) Cold-setting adhesive composition
JPS5217407A (en) Process for purification of formaldehyde
JPS5214730A (en) Process for preparation of m-toluidine containing protected p-amino gr oup
JPS52102280A (en) 5,7,8-trimethyltocotrienol-nicotinic acid esters and preparation there of
JPS5377026A (en) Preparation of p-nitrosoaniline
JPS5226550A (en) Composite stabilizer compositions
JPS51133699A (en) Process for storing the radioactive rare gas
JPS5625116A (en) Preparation of immunoglobulin having high content of monomer
JPS52102433A (en) Hypotensive agents containing 1,4-dihydroxy-1,4-di-(3,5-dimethoxy-4-hy droxyphenyl)butane-2,3-dicarboxylic acid dilactone as main component
JPS5260844A (en) Flame retardant polyamide resin compositions
JPS51137135A (en) Combustion system
JPS51138201A (en) Boiler reducing nitrogen oxide quantity produced
JPS51128420A (en) A method for preparing a pharmaceutical containing enzymes
JPS51145594A (en) Preparation of polyester
JPS5337690A (en) Novel pyridinophans their preparation and racemization catalysis containing the same for amino acids
JPS5231031A (en) Process for preparation of substituted phosphonic acid derivatives